Torrent [TORNTPHARM] vs Dr. Reddy's [DRREDDY] Detailed Stock Comparison

Torrent Pharmaceuticals Ltd.

NSE
Loading...

Dr. Reddy's Laboratories Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Torrent Pharmaceuticals Ltd. wins in 11 metrics, Dr. Reddy's Laboratories Ltd. wins in 9 metrics, with 0 ties. Torrent Pharmaceuticals Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Torrent Pharmaceuticals Ltd. Dr. Reddy's Laboratories Ltd. Better
P/E Ratio (TTM) 61.35 19.40 Dr. Reddy's Laboratories Ltd.
Price-to-Book Ratio 16.50 2.94 Dr. Reddy's Laboratories Ltd.
Debt-to-Equity Ratio 33.40 18.03 Dr. Reddy's Laboratories Ltd.
PEG Ratio 2.35 -1.35 Torrent Pharmaceuticals Ltd.
EV/EBITDA 34.44 12.80 Dr. Reddy's Laboratories Ltd.
Profit Margin (TTM) 17.83% 16.36% Torrent Pharmaceuticals Ltd.
Operating Margin (TTM) 26.70% 16.42% Torrent Pharmaceuticals Ltd.
EBITDA Margin (TTM) 26.70% 16.42% Torrent Pharmaceuticals Ltd.
Return on Equity 25.18% 16.10% Torrent Pharmaceuticals Ltd.
Return on Assets (TTM) 12.75% 7.96% Torrent Pharmaceuticals Ltd.
Free Cash Flow (TTM) $19.73B $12.03B Torrent Pharmaceuticals Ltd.
Dividend Yield 0.83% 11.59% Dr. Reddy's Laboratories Ltd.
1-Year Return 40.54% -6.39% Torrent Pharmaceuticals Ltd.
Price-to-Sales Ratio (TTM) 10.94 3.17 Dr. Reddy's Laboratories Ltd.
Enterprise Value $1,413.15B $1,085.11B Torrent Pharmaceuticals Ltd.
EV/Revenue Ratio 11.09 3.14 Dr. Reddy's Laboratories Ltd.
Gross Profit Margin (TTM) 75.42% 53.63% Torrent Pharmaceuticals Ltd.
Revenue per Share (TTM) $376 $415 Dr. Reddy's Laboratories Ltd.
Earnings per Share (Diluted) $67.11 $67.88 Dr. Reddy's Laboratories Ltd.
Beta (Stock Volatility) 0.19 0.30 Torrent Pharmaceuticals Ltd.

Torrent Pharmaceuticals Ltd. vs Dr. Reddy's Laboratories Ltd. Stock Performance Analysis

Loading Price Chart...

TORNTPHARM
DRREDDY

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Torrent Pharmaceuticals Ltd.-1.47%2.12%2.23%5.56%19.07%17.04%
Dr. Reddy's Laboratories Ltd.0.32%0.31%-4.28%0.20%-0.09%2.08%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Torrent Pharmaceuticals Ltd.40.54%146.00%215.51%578.42%2,737.14%10,046.95%
Dr. Reddy's Laboratories Ltd.-6.39%29.74%20.69%112.36%310.53%902.28%

Performance & Financial Health Analysis: Torrent Pharmaceuticals Ltd. vs Dr. Reddy's Laboratories Ltd.

MetricTORNTPHARMDRREDDY
Market Information
Market Cap i₹1.39T₹1.10T
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i393,9153,912,162
90 Day Avg. Volume i399,1292,668,229
Last Close₹4,504.00₹1,279.50
52 Week Range₹3,140.10 - ₹4,712.90₹1,148.40 - ₹1,375.90
% from 52W High-4.43%-7.01%
All-Time High₹4,712.90 (May 25, 2026)₹1,421.49 (Aug 19, 2024)
% from All-Time High-4.43%-9.99%
Growth Metrics
Quarterly Revenue Growth0.18%0.04%
Quarterly Earnings Growth0.26%-0.14%
Financial Health
Profit Margin (TTM) i0.18%0.16%
Operating Margin (TTM) i0.27%0.16%
Return on Equity (TTM) i0.25%0.16%
Debt to Equity (MRQ) i33.4018.03
Cash & Liquidity
Book Value per Share (MRQ)₹249.47₹447.25
Cash per Share (MRQ)₹23.47₹99.20
Operating Cash Flow (TTM) i₹27.02B₹63.11B
Levered Free Cash Flow (TTM) i₹19.11B₹13.47B
Dividends
Last 12-Month Dividend Yield i0.83%11.59%
Last 12-Month Dividend i₹35.00₹146.30

Valuation & Enterprise Metrics Analysis: Torrent Pharmaceuticals Ltd. vs Dr. Reddy's Laboratories Ltd.

MetricTORNTPHARM (Apr 26, 2026)DRREDDY (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i61.3519.40
Forward P/E i63.9224.12
PEG Ratio i2.35-1.35
Price to Sales (TTM) i10.943.17
Price to Book (MRQ) i16.502.94
Market Capitalization
Market Capitalization i₹1.39T₹1.10T
Enterprise Value i₹1.41T₹1.09T
Enterprise Value Metrics
Enterprise to Revenue i11.093.14
Enterprise to EBITDA i34.4412.80
Risk & Other Metrics
Beta i0.190.30
Book Value per Share (MRQ) i₹249.47₹447.25

Financial Statements Comparison: Torrent Pharmaceuticals Ltd. vs Dr. Reddy's Laboratories Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricTORNTPHARM (2025)DRREDDY (2025)
Revenue/Sales i113.17B325.54B
Cost of Goods Sold i28.84B135.11B
COGS % of Revenue i25.5%41.5%
Gross Profit i84.33B190.43B
Gross Margin i74.5%58.5%
Research & Development i304.20M27.38B
Operating Income (EBIT) i29.26B72.01B
Operating Margin i25.9%22.1%
EBITDA i37.25B91.97B
EBITDA Margin i32.9%28.3%
Pre-Tax Income i26.73B76.78B
Pre-Tax Income % of Revenue i23.6%23.6%
Income Tax i7.62B19.54B
Income Tax % of Revenue i6.7%6.0%
Net Income (Profit) i19.11B57.25B
Profit Margin i16.9%17.6%

Balance Sheet & Liquidity Metrics

MetricTORNTPHARM (2025)DRREDDY (2025)
Cash & Equivalents i5.73B14.65B
Total Current Assets i56.23B250.11B
Total Current Assets % of Revenue i49.7%76.8%
Total Current Liabilities i47.17B130.39B
Total Current Liabilities % of Revenue i41.7%40.1%
Long-Term Debt i13.38B7.86B
Long-Term Debt % of Revenue i11.8%2.4%
Total Shareholders Equity i75.91B337.17B
Retained Earnings iN/A315.79B
Retained Earnings % of Revenue i0.0%97.0%
Property, Plant & Equipment i2.99B0

Cash Flow Statement Comparison

MetricTORNTPHARM (2025)DRREDDY (2025)
Operating Cash Flow i27.02B64.09B
Operating Cash Flow % of Revenue i23.9%19.7%
Capital Expenditures i-5.94B-26.99B
Free Cash Flow i19.73B12.03B
FCF Margin i17.4%3.7%
Debt Repayment i-9.26B-1.29B
Common Stock Repurchase iN/A-1.39B

Short Interest & Institutional Ownership Analysis

MetricTORNTPHARMDRREDDY
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i338.45M832.57M
Float Shares i103.94M599.15M
% Held by Insiders i71.13%29.45%
% Held by Institutions i14.81%51.84%
% Held by Public i14.06%18.71%

Dividend Analysis & Yield Comparison: Torrent Pharmaceuticals Ltd. vs Dr. Reddy's Laboratories Ltd.

MetricTORNTPHARMDRREDDY
Last 12-Month Dividend i₹35.00₹146.30
Last 12-Month Dividend Yield i0.83%11.59%
3-Year Avg Annual Dividend i₹32.33₹49.30
3-Year Avg Dividend Yield i0.52%3.74%
3-Year Total Dividends i₹97.00₹147.90
Ex-Dividend DateFeb 18, 2026Jul 10, 2025